Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Health Catalyst (HCAT) Preferred Stock Liabilities (2018 - 2019)

Health Catalyst filings provide 2 years of Preferred Stock Liabilities readings, the most recent being $584.6 million for Q2 2019.

  • On a quarterly basis, Preferred Stock Liabilities rose 69.32% to $584.6 million in Q2 2019 year-over-year; TTM through Jun 2019 was $584.6 million, a 69.32% increase, with the full-year FY2018 number at $409.8 million, up 27.45% from a year prior.
  • Preferred Stock Liabilities hit $584.6 million in Q2 2019 for Health Catalyst, up from $485.9 million in the prior quarter.
  • In the past five years, Preferred Stock Liabilities ranged from a high of $584.6 million in Q2 2019 to a low of $345.2 million in Q2 2018.